Constitutively Activated NLRP3 Inflammasome Causes Inflammation and Abnormal Skeletal Development in Mice

The NLRP3 inflammasome complex is responsible for maturation of the pro-inflammatory cytokine, IL-1β. Mutations in NLRP3 are responsible for the cryopyrinopathies, a spectrum of conditions including neonatal-onset multisystem inflammatory disease (NOMID). While excessive production of IL-1β and systemic inflammation are common to all cryopyrinopathy disorders, skeletal abnormalities, prominently in the knees, and low bone mass are unique features of patients with NOMID. To gain insights into the mechanisms underlying skeletal abnormalities in NOMID, we generated knock-in mice globally expressing the D301N NLRP3 mutation (ortholog of D303N in human NLRP3). NOMID mice exhibit neutrophilia in blood and many tissues, including knee joints, and high levels of serum inflammatory mediators. They also exhibit growth retardation and severe postnatal osteopenia stemming at least in part from abnormally accelerated bone resorption, attended by increased osteoclastogenesis. Histologic analysis of knee joints revealed abnormal growth plates, with loss of chondrocytes and growth arrest in the central region of the epiphyses. Most strikingly, a tissue “spike" was observed in the mid-region of the growth plate in the long bones of all NOMID mice that may be the precursor to more severe deformations analogous to those observed in NOMID patients. These findings provide direct evidence linking a NOMID-associated NLRP3-activating mutation to abnormalities of postnatal skeletal growth and bone remodeling.

[1]  J. Penninger,et al.  Lineage‐committed osteoclast precursors circulate in blood and settle down into bone , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  H. Hoffman,et al.  Autoinflammation: translating mechanism to therapy , 2011, Journal of leukocyte biology.

[3]  B. Guillotin,et al.  Osteoblast connexin43 modulates skeletal architecture by regulating both arms of bone remodeling , 2011, Molecular biology of the cell.

[4]  H. Hoffman,et al.  Genetic and Molecular Basis of Inflammasome-mediated Disease* , 2011, The Journal of Biological Chemistry.

[5]  R. Civitelli,et al.  N-cadherin and cadherin 11 modulate postnatal bone growth and osteoblast differentiation by distinct mechanisms , 2010, Journal of Cell Science.

[6]  Egil Lien,et al.  NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals , 2010, Nature.

[7]  P. Kovanen,et al.  Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation , 2010, PloS one.

[8]  K. Moore,et al.  NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.

[9]  Kate Schroder,et al.  The NLRP3 Inflammasome: A Sensor for Metabolic Danger? , 2010, Science.

[10]  N. Walsh,et al.  Bone remodeling in rheumatic disease: a question of balance , 2010, Immunological reviews.

[11]  J. Tschopp,et al.  The Inflammasomes , 2010, Cell.

[12]  Fuping Zhang,et al.  A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. , 2009, Immunity.

[13]  D. Kastner,et al.  Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. , 2009, Immunity.

[14]  D. Magne,et al.  TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells. , 2009, Life sciences.

[15]  R. Faccio,et al.  RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. , 2008, The Journal of clinical investigation.

[16]  W. Zou,et al.  RelB is the NF-κB subunit downstream of NIK responsible for osteoclast differentiation , 2008, Proceedings of the National Academy of Sciences.

[17]  S. Teitelbaum,et al.  The osteoclast: friend or foe? , 2008, Annual review of pathology.

[18]  P. Byers,et al.  Type XXVII collagen at the transition of cartilage to bone during skeletogenesis. , 2007, Bone.

[19]  B. Hallgrímsson,et al.  Inactivation of Pten in Osteo‐Chondroprogenitor Cells Leads to Epiphyseal Growth Plate Abnormalities and Skeletal Overgrowth , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  L. Joosten,et al.  TNF-induced structural joint damage is mediated by IL-1 , 2007, Proceedings of the National Academy of Sciences.

[21]  E. Remmers,et al.  The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. , 2007, Arthritis and rheumatism.

[22]  A. Poznanski,et al.  Arthropathy of neonatal onset multisystem inflammatory disease (NOMID/CINCA) , 2007, Pediatric Radiology.

[23]  G. Anderson,et al.  Inhibition of p38 Mitogen-Activated Protein Kinase Prevents Inflammatory Bone Destruction , 2006, Journal of Pharmacology and Experimental Therapeutics.

[24]  V. Dixit,et al.  Cryopyrin activates the inflammasome in response to toxins and ATP , 2006, Nature.

[25]  F. Martinon,et al.  Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.

[26]  L. Raisz Pathogenesis of osteoporosis: concepts, conflicts, and prospects. , 2005, The Journal of clinical investigation.

[27]  H. Kronenberg,et al.  Developmental regulation of the growth plate , 2003, Nature.

[28]  E. Remmers,et al.  De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. , 2002, Arthritis and rheumatism.

[29]  A. Fischer,et al.  Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. , 2002, American journal of human genetics.

[30]  S. Takeshita,et al.  TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. , 2000, The Journal of clinical investigation.

[31]  L. Avioli,et al.  Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Kang,et al.  Collagen-induced arthritis in rodents: a review of immunity to type II collagen with emphasis on the importance of molecular conformation and structure. , 1988, International reviews of immunology.